The role that cytokines play in the induction of Lyme arthritis is gradually being delineated. We showed previously that severe arthritis developed in a T-cell-driven murine model, even in mice lacking interleukin-17A (IL-17A) and administered anti-gamma-interferon (IFN-γ ) antibody. Increased levels of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), two pro-inflammatory cytokines, were detected in cultures of popliteal lymph node cells obtained from these mice. We hypothesized that concomitantly administered anti-IL-6, anti-TNF-α and anti-IFN-γ antibodies would inhibit the development of arthritis in IL-17A-deficient mice. Our results showed that swelling of the hind paws and histopathological changes consistent with arthritis were significantly reduced in IL-17A-deficient mice that administered the three anti-cytokine antibodies. These results suggest that treatment with multiple anti-cytokine antibodies can abrogate the induction of Lyme arthritis in mice.
INTRODUCTION
IL-17A, a proinflammatory cytokine produced by T helper (Th) 17 lymphocytes, is associated with the induction of arthritis in humans infected with Borrelia burgdorferi, the causative agent of Lyme disease (Infante-Duarte et al. 2000; Codolo et al. 2008 Codolo et al. , 2013 ; D'Elios, Codolo and de Bernard 2009; Henningsson et al. 2011; Strle et al. 2017) . The role of IL-17A in the induction of arthritis is further supported by animal studies (Burchill et al. 2003; Nardelli et al. 2004 Nardelli et al. , 2008 Knauer et al. 2007; Kotloski et al. 2008; Oosting et al. 2011; Kuo et al. 2011; Hansen et al. 2013 Hansen et al. , 2016 . When Borrelia-primed and infected mice, a model of T-cell-driven arthritis, were depleted of IL-17A with antibodies, development of arthritis was suppressed (Burchill et al. 2003; Nardelli et al. 2008) . However, we (Kuo et al. 2016; Kuo, Warner and Schell 2017) recently showed that Borrelia-primed and infected mice developed arthritis under IL-17A deficiency. These IL-17A-deficient mice had high levels of IFN-γ in their sera, and popliteal lymph node cells produced increased amounts of the cytokine (Kuo et al. 2016) . Contrary to our hypothesis, however, neutralization of IFN-γ in these mice failed to prevent the development of arthritis (Kuo, Warner and Schell 2017) . Other studies have also shown that IFN-γ is not required for the induction of arthritis (Brown and Reiner 1999; Glickstein, Edelstein and Dong 2001; Burchill et al. 2003; Nardelli et al. 2004; Lee et al. 2013) . These findings suggested that cytokines other than IL-17A and IFN-γ may be responsible for the induction of arthritis.
Although neutralization of IFN-γ and absence of IL-17A failed to prevent arthritis, increased levels of TNF-α and IL-6, two other proinflammatory cytokines, were significantly detected in these mice (Kuo, Warner and Schell 2017) . A role for TNF-α and IL-6 in Borrelia-induced arthritis has been previously reported (Yin et al. 1997; Christopherson et al. 2003; Munson et al. 2006; Shin, Glickstein and Steere 2007; Codolo et al. 2008) . For example, increased levels of TNF-α have been detected in immune cells from human Lyme disease patients after in vitro exposure to Borrelia (Yin et al. 1997) . Similarly, IL-6 has been shown to be secreted by T cells and monocytes from human Lyme disease patients (Codolo et al. 2008) . Most importantly, Shin, Glickstein and Steere (2007) reported high levels of TNF-α, IL-6 and IFN-γ when examining synovial fluids of human Lyme arthritis patients. Collectively, these findings suggest a correlation between the induction of Borrelia-induced arthritis and elevated expressions of TNF-α and IL-6.
We hypothesized that combined neutralization of IFN-γ , TNF-α and IL-6 would lessen the development of arthritis in Borrelia-primed and infected IL-17A-deficient C57BL/6 mice. Our results confirmed this to be true. Swelling of the hind paws of mice and histopathological changes were less in mice treated with all three anti-cytokine antibodies than other experimental groups.
MATERIALS AND METHODS

Mice
Six-to eight-week-old male IL-17A-deficient C57BL/6 mice were provided by Dr Bruce Klein and Dr Marcel Wuethrich (University of Wisconsin School of Medicine and Public Health) with permission from Dr Yoichiro Iwakura (University of Tokyo's Institute of Medical Science). Wild-type C57BL/6J mice of the same age were purchased from Jackson Laboratory (West Sacramento, CA). All mice were kept at the animal facility located at the University of Wisconsin School of Medicine and Public Health. Mice were maintained under a pathogen-free condition at 21
• C with food and acidified water provided ad libitum during daily cycles of 12 h of light and darkness. Experimental protocols were approved by the Animal Care and Use Committee of the University of Wisconsin School of Medicine and Public Health.
Organisms and preparation
Low-passage-number (<10) virulent Borrelia bissettii (formerly known as B. burgdorferi strain C-1-11; isolated from Microtus pennsylvanicus) and B. burgdorferi isolate 297 (isolated from human spinal fluid) were cultured in modified Barbour-StoennerKelly (BSK) medium until reaching a concentration of 10 7 spirochetes/ml. Samples of 500 μl were dispensed into 1.5 ml screw cap tubes (Sarstedt, Newton, NC) containing 500 μl of BSK medium with 10% glycerol (Sigma-Aldrich, St. Louis, MO). Spirochetes were stored at -70 • C until used.
Priming of mice
A frozen suspension of B. bissettii was thawed, heated in a water bath at 56
• C for 30 min and examined by darkfield microscopy for absence of motility. Heat-inactivated B. bissettii organisms were then washed three times by centrifugation at 10 000 × g with ice-cold phosphate-buffered saline (PBS, pH 7.4) that was filter-sterilized with a 0.2-μm-pore-size filter (Gelman Sciences, Ann Arbor, MI). Subsequently, washed B. bissettii organisms were resuspended in PBS and mixed with a volume of 1% aluminum hydroxide (Reheis, Berkeley Heights, NJ) to yield a concentration of 2 × 10 6 spirochetes/ml. Mice were then anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the sural region near the popliteal lymph node of the ventral right hind limb of each mouse with 0.10 ml of the vaccine using a 23-gauge needle. In another study, mice were primed in the left hind paw to avoid performing priming, infection and treatment with anti-cytokines in the right hind paw. Non-primed mice were injected with PBS and 1% aluminum hydroxide without B. burgdorferi.
Infection of mice
A frozen suspension of B. burgdorferi isolate 297 was thawed and mixed with 4 ml of fresh BSK medium. The spirochetal culture was incubated at 32
• C until reaching a concentration of 2 × 10 7 viable spirochetes/ml. Twenty-one days after priming of mice with heat-inactivated B. bissettii, mice were anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the right hind paw with 1 × 10 6 (50 μl) B. burgdorferi isolate 297 organisms with a 27-gauge needle. The heterologous infection with B. burgdorferi isolate 297 induces arthritis and is not affected by the presence of anti-B. bissettii antibodies induced after priming with B. bissettii. Infection with viable, but not non-viable, heterologous Borrelia organisms can induce arthritis (Lim et al. 1995) . If priming and infection are conducted with the same isolate of B. burgdorferi, arthritis will not develop if specific borreliacidal antibodies are present (Croke et al. 2000) . Uninfected mice were injected with BSK medium.
Administration of anti-IFN-γ , anti-TNF-α and/or anti-IL-6 antibodies
Mice were injected singularly with 1 μg (in 0.1 ml filter-sterilized PBS, pH 7.4) polyclonal goat anti-mouse IFN-γ , TNF-α or IL-6 antibody (R&S Systems, Minneapolis, MN) in the right hind paw 1 h after infection and daily thereafter for 5 days. Other groups of mice were concomitantly administered the three anti-cytokine antibodies with 1 μg each per day. Immunoglobulin G isotype control antibody was administered as the control.
Assessment of swelling
Swelling of the right hind paws of mice was measured with a digital caliper (Mitutoyo American Corporation, Aurora, IL) with a sensitivity of 0.01 mm prior to infection with B. burgdorferi isolate 297 and every other day for 8 days. We measured hind paw swelling 1 h before delivery of antibodies. Caliper values within a group were averaged to obtain the mean caliper value for comparison of the degree of swelling.
Histological examination
Mice were euthanized with isoflurane 8 days after infection, and the right hind paw of each mouse was amputated at midfemur. Paws were first placed in decalcifying solution (Lerner Laboratories, Pittsburgh, PA) for 24 h, and then stored in 10% neutral buffered formalin solution for 48 h (Sigma-Aldrich, St. Louis, MO). Paws were then placed in tissue-embedding cassettes (Fisher Scientific, Hanover Park, IL), embedded in paraffin and cut into three to five 6-μm-thick sections. Each section of the hind paws was placed onto a glass slide and stained with hematoxylin and eosin. Sections were cryptically coded, and a board-certified pathologist (T. F. Warner) performed fully blinded histopathological examinations of the tissues. The following ratings were used: 0, no histopathological changes; 1, mild infiltration of polymorphonuclear cells; 2, hyperplasia or villus formation with moderate infiltration of polymorphonuclear cells and lymphocytes; 3, severe hyperplasia with villus formation and infiltration of polymorphonuclear cells and lymphocytes; 4, extremely severe hyperplasia with villus formation and infiltration of polymorphonuclear cells and lymphocytes.
Selection of cytokines
Preliminary studies using enzyme-linked immunosorbent assays were performed to detect levels of various cytokines, including IFN-γ , TNF-α, IL-4, IL-6, IL-10 and IL-21 in the sera of Borrelia-primed and infected IL-17A-deficient mice compared to controls. Cytokines with elevated levels were selected for neutralization studies.
Flow cytometry for confirmation of neutralization of cytokines
Popliteal lymph nodes of mice were obtained 8 days after infection. Single-cell suspensions of lymph node cells were prepared by passing cells through a sterile nylon mesh screen (Fisher, Hanover Park, IL) into cold filter-sterilized PBS in centrifuge tubes on ice. Total numbers of viable cells were determined using trypan blue exclusion and enumeration with a hemocytometer. The suspensions were diluted to 1 × 10 7 cells/ml.
A total of 5 × 10 5 cells from each sample were then transferred to a sterile tissue culture treated 96-well plate (Corning, Corning, NY). Cells were incubated in the dark at 4
• C for 30 min during surface staining with fluorescein isothiocyanateconjugated rat anti-mouse CD4 antibody (BD Biosciences, San Jose, CA). The antibody-to-cell ratio was determined to maximize recognition of CD4 + cells. Isotype controls were also included. After incubation, cells were permeabilized and stained intracellularly with allophycocyanin-conjugated rat anti-mouse IFN-γ antibody, phycoerythrin-cyanine 7-conjugated rat antimouse TNF-α antibody and BD Horizon V450-conjugated rat anti-mouse IL-6 antibody (BD Biosciences, San Jose, CA) in the dark at 4
• C for 30 min. Cells were then fixed with 5% formalin, and data were acquired using a BD LSRFortessa cell analyzer (BD Biosciences, San Jose, CA). Events were gated to include viable lymphocytes that were CD4 + and evaluated for expressing IFN-γ , TNF-α or IL-6. The percentage of these specific cells was determined from the entire lymphoid organ population. Thirty thousand gated events were collected and analyzed with FlowJo single cell analysis software (Tree Star, Ashland, OR).
Statistics
Swelling of the hind paws and histopathological examinations among different groups of Borrelia-primed and infected mice were evaluated by Fisher's protected least-significant-difference test and one-way analysis of variance through R Commander. The alpha level was set at 0.05. Data are presented as the average with two standard errors of the mean.
RESULTS
Hind paw swelling in IL-17A-deficient C57BL/6 mice treated with or without anti-cytokine antibody
The purpose of this study was to determine if neutralization of IFN-γ , TNF-α and IL-6, alone or in combination would affect the development of arthritis in Borrelia-primed and infected IL-17A-deficient mice. Borrelia-primed and infected wild-type and IL-17A-deficient mice were randomly assigned to receive the following treatments: isotype control antibody, anti-IFN-γ antibody alone, anti-TNF-α antibody alone, anti-IL-6 antibody alone or all three anti-cytokine antibodies. Each treatment group had four mice, and the study was performed three different times.
Cultures of popliteal lymph nodes from each group were also evaluated to determine the level of the cytokines by use of flow cytometry.
Borrelia-primed and infected wild-type (Fig. 1A) and IL-17A-deficient (Fig. 1B) mice administered anti-IFN-γ , anti-TNF-α, anti-IL-6 or an isotype antibody developed severe swelling of the hind paws from days 2 to 8 after infection compared to the non-primed and uninfected IL-17A-deficient and wild-type mice. Hind paw swelling did not differ among mice treated with single anti-cytokine antibodies or the isotype control antibody. In contrast, hind paw swelling in Borrelia-primed and infected IL-17A-deficient mice treated with a combination of all three anti-cytokine antibodies was comparable to the control groups at days 0 to 4 after infection. On days 6 to 8 of infection, Borrelia-primed and infected IL-17A-deficient mice administered all three anti-cytokine antibodies displayed significantly (P < 0.05) less swelling of the hind paws than mice treated with only one anti-cytokine antibody or the isotype control. No difference among all Borrelia-primed and infected wild-type mice was observed at days 0 to 6 after infection. Moreover, on day 8, IL-17A-deficient mice had significantly less swelling of the hind paws than wild-type mice after treatment with the three anticytokine antibody cocktail and were comparable to non-primed and uninfected mice. Swelling of wild-type counterparts with the three anti-cytokine antibody at day 8 was comparable to day 7, but was significantly less than all other primed and infected wild-type mice, but higher than non-primed and uninfected controls. Similar results were obtained when this study was repeated twice.
In a separate experiment, the route of priming was altered. Instead of performing priming, infection and injection of cytokines in the same hind paw, priming with Borrelia was performed using the opposite hind paw. Similar results were obtained to those described above.
Detection of neutralization of cytokines
From our preliminary studies, cytokine levels from pooled sera of mice were detected. After treatment with each specific anticytokine, the cytokines were not detected in serum. We decided to focus on examining cytokine expressions in lymph node cells from the drainage arthritic site. From our previously published studies, the percentage of CD4 T cells was lower compared to other published studies since our cells were not stimulated in vitro overnight or for days. Moreover, plated cells lose characteristics from in vivo cells through time. To better examine the effects of the anti-cytokine antibodies on arthritic development and immune cells, we immediately proceeded to cell extractions and flow detection after harvesting lymph nodes.
Cultures of popliteal lymph node cells were evaluated to confirm neutralization of IFN-γ , TNF-α and IL-6 by using flow cytometry. CD4
+ T cells are the main immune cells involved in the induction of arthritis and were examined for their contribution in the production of cytokines. Similar to our previous study (Kuo, Warner and Schell 2017) , cytokines were minimally detected upon treatment with the antibodies (data not shown).
Histopathological confirmation of arthritis
Minimal or mild hyperplasia, villus formation and macrophage infiltration were observed in the synovial of all Borrelia-primed and infected IL-17A-deficient and wild-type mice with or without single anti-cytokine antibody treatment (Table 1 ). These mice also had moderate-to-severe infiltration of lymphocytes in the synovium and perisynovium. In contrast, IL-17A-deficient mice treated with all three anti-cytokine antibodies showed no hyperplasia or villus formation in the synovium. Minimal to mild hyperplasia and villus formation were detected in wildtype mice treated with the three anti-cytokine antibodies. Mild infiltration of lymphocytes was detected in the synovium of IL-17A-deficient and wild-type mice treated with the three anticytokine antibodies. However, infiltration of lymphocytes in the perisynovium was moderate to severe in Borrelia-primed and infected wild-type mice, but mild in IL-17A-deficient mice treated with the three anti-cytokine antibodies. No histopathological changes were detected in non-primed and uninfected IL-17A-deficient and wild-type mice (data not shown). Similar histopathological changes were obtained with Borrelia-primed and infected IL-17A-deficient mice treated with three anticytokine antibodies when the route of priming was altered (Fig. 2) .
DISCUSSION
IL-17A has been shown to be associated with the induction of human Lyme arthritis (Infante-Duarte et al. 2000; Codolo et al. 2008 Codolo et al. , 2013 Strle et al. 2017) . For instance, human T cells were observed by Infante-Duarte et al. (2000) to produce IL-17A upon interaction with borrelial outer surface protein A. Moreover, neutrophil activating protein A of Borrelia burgdorferi stimulated release of IL-17A from synovial T cells of human Lyme arthritis patients (Codolo et al. 2008 (Codolo et al. , 2013 . Recently, Strle et al. (2017) reported elevated levels of IL-17A and other Th17-associated cytokines in sera from human patients with early borrelial infections and in sera and synovial fluid from patients with antibiotic-refractory Lyme arthritis. Taken together, these results suggest that IL-17A is an important cytokine associated with Lyme arthritis. Our Borrelia-priming and infection mouse model also supports a role for IL-17A and T-cell-induced cytokines in the development of Lyme arthritis (Burchill et al. 2003; Christopherson et al. 2003; Nardelli et al. 2004 Nardelli et al. , 2005 Nardelli et al. , 2006 Nardelli et al. , 2008 Amlong et al. 2006; Kotloski et al. 2008; Kuo et al. 2011; Hansen et al. 2013) . Although treatment of wild-type C57BL/6 mice with anti-IL-17A antibody was shown to decrease the severity of swelling and pathology of the hind paws , we (Kuo et al. 2016) showed that arthritis developed in Borrelia-primed and infected IL-17A-deficient C57BL/6 mice. Lasky et al. (2015) also reported development of Lyme arthritis in mice deficient for IL-17 receptor A. These findings suggest that cytokines other than IL-17A are involved in the induction of arthritis.
Recently, we detected high levels of IFN-γ in sera and popliteal lymph node cells of arthritic, Borrelia-primed and infected IL-17A-deficient mice (Kuo et al. 2016) . IFN-γ has been reported to drive inflammation upon borrelial infection (Yssel et al. 1991; Gross, Steere and Huber 1998; Yin et al. 1997; Strle et al. 2012) . Surprisingly, we subsequently showed that treatment of these mice with anti-IFN-γ antibody failed to prevent arthritis (Kuo, Warner and Schell 2017) . In that study, we observed elevated levels of TNF-α and IL-6 in arthritic Borrelia-primed and infected IL-17A-deficient C57BL/6 mice treated with anti-IFN-γ antibody (Kuo, Warner and Schell 2017) . Neutralization of either TNF-α or IL-6 failed to prevent arthritis in anti-IFN-γ -treated Borrelia-primed and infected IL-17A-deficient C57BL/6 mice (data not shown). Table 1 . Histopathological changes observed in the tibiotarsal joints of Borrelia-primed and infected IL-17A-deficient and wild-type C57BL/6 mice that were administered anti-IFN-γ , anti-TNF-α and anti-IL-6 separately or a combination of the three anti-cytokine antibodies. Here, we show that treatment of Borrelia-primed and infected IL-17A-deficient mice with a cocktail of antibodies against IFN-γ , TNF-α and IL-6 prevented the development of arthritis. No difference in swelling of the hind paws was detected between these mice and non-primed and uninfected mice. Histopathological responses confirmed these results. Only minor infiltration of inflammatory cells into the synovial tissue was observed in Borrelia-primed and infected IL-17A-deficient mice treated with all three anti-cytokine antibodies. In contrast, Borrelia-primed and infected IL-17A-deficient and wild-type mice developed severe histopathological changes in the absence of treatment with all three anti-cytokine antibodies. In another report, treatment of Borrelia-primed and infected wild-type mice with anti-IL-17, anti-transforming growth factor beta, and anti-IL-6 antibodies significantly reduced swelling of the hind paws and prevented the development of arthritic changes in the ankle joints . Taken together, these studies support the concept that neutralizations of different proinflammatory cytokine arrangements can contribute to the prevention of arthritis.
Why did concurrent neutralization of IFN-γ , TNF-α and IL-6 prevent arthritis in Borrelia-primed and infected IL-17A-deficient mice? Although we do not know the mechanism by which the three anti-cytokine antibodies inhibited the development of arthritis, augmentation of CD4 + CD25 + Foxp3 + regulatory T cells is one possibility. We showed previously that IFN-γ -deficient mice treated with anti-IL-17 antibody develop a greater number of suppressor cells that prevented arthritis (Nardelli et al. 2004 (Nardelli et al. , 2005 , but treatment of Borrelia-primed and infected mice with anti-CD25 antibody led to the development of severe, destructive arthritis (Nardelli et al. 2004 (Nardelli et al. , 2005 . Most importantly, our results apply only to the induction phase of arthritis; different anti-cytokine antibody arrangements may be required for the resolution of Borrelia-induced arthritis.
Our results also confirmed that neutralization of a single cytokine failed to prevent arthritis in IL-17A-deficient mice. When Borrelia-primed and infected IL-17A-deficient mice were administered only anti-TNF-α or anti-IL-6 antibody, swelling of the hind paws with moderate-to-severe histopathological changes was detected. These results did not differ from mice treated with an isotype control antibody. Similar results were reported in Borrelia-primed and infected IL-17A-deficient mice treated with anti-IFN-γ antibody (Kuo, Warner and Schell 2017) . Moreover, neutralization of two cytokines did not substantially reduce arthritis (data not shown). These findings demonstrate the complexity of the cytokine response and necessity for neutralization of multiple cytokines to abrogate the induction of arthritis.
The chronology of events that led to prevention of arthritis by the three anti-cytokine antibodies in IL-17A-deficient mice is unknown. Perhaps the anti-cytokine antibodies work concomitantly or induce other cytokines to trigger the abrogation of arthritis. We do not know the order in which the anti-cytokine antibodies must be administered to prevent arthritis. Since delivery of one or two anti-cytokine antibodies does not prevent the induction of arthritis, the order of administration may be less important. It is also plausible that IL-17A-deficient mice have developed compensatory cytokine mechanisms that differ from those expressed in wild-type mice. These compensatory mechanisms in IL-17A-deficient mice may be more susceptible to anti-cytokine antibody treatment. Additional studies are needed in wild-type mice to determine how IL-17A affects the cytokine response compared to the cytokine response in Borreliaprimed and infected IL-17A-deficient mice.
In summary, multiple cytokines are required for the development of arthritis in Borrelia-primed and infected IL-17A-deficient and wild-type mice. This study clearly shows that neutralization of cytokines is a valuable tool for determining the contribution that each cytokine plays in the induction of Lyme arthritis. Further investigations are needed to determine the cytokines involved in the resolution of arthritis.
